Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
0.9454
-0.0446 (-4.51%)
At close: Feb 6, 2026, 4:00 PM EST
0.9643
+0.0189 (2.00%)
After-hours: Feb 6, 2026, 7:06 PM EST

Mainz Biomed Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-18.97-21.65-26.3-26.39-11.69-0.59
Depreciation & Amortization
1.021.020.870.380.070.06
Loss (Gain) From Sale of Assets
-0.08-0.08----
Asset Writedown & Restructuring Costs
0.050.05----
Stock-Based Compensation
1.451.144.019.826.43-
Provision & Write-off of Bad Debts
-0.01-0.010.010.07-0
Other Operating Activities
1.82.4-0.46-0.042.11-0
Change in Accounts Receivable
0.030.060.02-0.210.02-0.1
Change in Inventory
-0.090.03-0.5-0.17--
Change in Accounts Payable
-0.80.080.721.650.660.16
Change in Unearned Revenue
-0.12-0.14-0.060.170.01-0
Change in Other Net Operating Assets
0.260.01-0.24-0.05-0.83-0
Operating Cash Flow
-15.46-17.09-21.94-14.77-3.22-0.47
Capital Expenditures
0.01-0.1-1.2-0.66-0.02-0.01
Sale of Property, Plant & Equipment
0.020.02----
Cash Acquisitions
----1.22-
Divestitures
0.030.03----
Sale (Purchase) of Intangibles
-0.3-0.15-0.7---
Investing Cash Flow
-0.23-0.2-1.9-0.661.2-0.01
Short-Term Debt Issued
----00.03
Long-Term Debt Issued
-4.3110.12-0.240.41
Total Debt Issued
1.344.3110.12-0.250.44
Short-Term Debt Repaid
----0.11--
Long-Term Debt Repaid
--1.48-2.29-0.2-0.06-0.04
Total Debt Repaid
-1.4-1.48-2.29-0.3-0.06-0.04
Net Debt Issued (Repaid)
-0.062.837.83-0.30.190.4
Issuance of Common Stock
16.7813.766.3924.2510.43-
Financing Cash Flow
16.7216.614.2323.9410.610.4
Foreign Exchange Rate Adjustments
-0.1-0.15-0.46-0.10.010
Net Cash Flow
0.93-0.84-10.078.418.6-0.08
Free Cash Flow
-15.45-17.19-23.14-15.43-3.24-0.48
Free Cash Flow Margin
-2340.66%-1923.39%-2583.83%-2911.63%-560.67%-96.93%
Free Cash Flow Per Share
-6.83-17.76-56.98-43.59-17.96-3.41
Cash Interest Paid
0.080.20.150.130.050.02
Levered Free Cash Flow
-8.19-10.45-13.61-5.70.04-
Unlevered Free Cash Flow
-7.79-9.78-13.26-5.520.26-
Change in Working Capital
-0.720.05-0.061.39-0.140.06
Updated Sep 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q